Particle Data Platform

IVF IQ Data Controversy

26:3727:46 · 69s

Max reveals a U.S. company used UK patient data to market embryo IQ selection—legal stateside but banned in Britain—exposing global regulatory gaps.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.